Clinical Trial Update: Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether fenofibrate can safely and effectively prevent doxorubicin-induced cardiotoxicity in patients with breast cancer (Stage 2-3); s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Tanta University | Conditions: Breast Cancer Stage 2 and 3 | Phase 2 | Status: COMPLETED